Market Minds Advisory
Chickpea Protein Market

Chickpea Protein Market: Chickpea Protein Market. Neutral Flavour Claims, Wet Fractionation Cost and Allergen-Friendly Positioning

Chickpea protein offers a non-GMO, allergen-friendly and mild-tasting alternative to pea and soy for plant-based foods, but higher raw material cost, limited processing capacity and flavour challenges mean scale and functionality decide who wins.

Lead Analyst

Published

September 2026

Make Smarter Decisions with Customized Research Insights

Request a free sample report and evaluate market opportunities, growth trends, and competitive dynamics relevant to your business needs.

2025 MARKET VALUE$0.5BMarket Size 2025
2036 FORECAST VALUE$1.4BBase Case , 2026 to 2036
CAGR 2026 TO 203611.0 %Bull 12.3% / Bear 9.7%
INCREMENTAL OPPORTUNITY$0.9BNet 10- year value creation
EXPANSION MULTIPLE2.84x2036 value over 2026 base
Strategic Levers
M&A Pipeline
Regional Outlook
Country Rankings
Competitive Intelligence
Segmental Deep-dive
Call-Us : 91 93563 13602

Executive Snapshot and Market Trajectory.

Chickpea protein is a plant protein extracted from chickpeas, marketed as non-GMO, soy-free and milder in taste than many rivals. Growth comes from new plant-based launches, but cost and limited processing capacity keep chickpea protein a premium choice next to pea. Buyers ask for proof. Flavour decides.
Chickpea Protein Isolate grows fastest as dairy alternative, egg alternative and sports nutrition brands seek high-purity, neutral-tasting protein, while chickpea flour and concentrates still carry the largest volume in snacks and bakery. North America holds the largest share because American brands lead plant-based launches, with Western Europe close behind on clean-label and allergen-conscious demand. Raw material supply comes from India, Australia, Canada and Turkey.
Competition is fragmented, with Israeli and American chickpea protein specialists, European pulse processors and global ingredient groups competing on purity, functionality and price per kilogram of protein. Novel food rules for extracts in some markets, labelling of legumes as allergens, and requirements for clean-label and non-GMO claims shape entry, and buyers audit protein content, flavour profile and pesticide residues before they qualify a supplier for launches. Compliance cost favours larger suppliers. Approvals take months.
Market Definition
The market covers global sales of chickpea-derived protein ingredients, including chickpea protein isolates, concentrates, textured chickpea protein, functional and hydrolysed fractions and protein-enriched chickpea flour, sold to food and beverage makers, sports nutrition brands and pet food makers. It excludes whole chickpeas, hummus and finished chickpea foods, standard unenriched chickpea flour, and other pulse proteins such as pea, fava and lentil.
Base Year Value
$0.5B in 2025 (MMA Primary Research Dataset, September 2026)
Forecast Period
2026 to 2036, eleven discrete annual values
CAGR
11.0% base case. Bull 12.3%. Bear 9.7%.
Fastest Growth Segment
Chickpea Protein Isolate: 15.4% CAGR
Fastest Growth Country
India: 14.0% CAGR
Fastest Growth Region
South Asia and Pacific: 13.1% CAGR
Largest Region
North America: 30% of 2025 global value
Market Leaders
ChickP, Nutriati, Ingredion, Emsland Group, ADM. Source: MMA Analysis, company annual reports.
Primary Survey
n=3,800 procurement and R&D decision-makers, Q4 2025, six countries
Methodology
Demand-side build-up, cross-validated against public data, 47 expert interviews

Chickpea Protein Market Forecast Scenarios

chickpea-protein-market-size-forecast-scenario-1789966722066
Between 2020 and 2025 the market grew at about 10.0% a year from a small base, helped by the search for soy-free and non-GMO plant proteins, launches of chickpea-based dairy and egg alternatives and investment in new fractionation plants. Growth slowed in 2023 when plant-based food sales cooled and chickpea prices rose. Textured and isolate formats gained share over flour.
The base case rests on three commercial mechanisms. First, food makers diversify away from soy and pea for allergen, supply and taste reasons, giving chickpea a niche in premium foods. Second, wet fractionation and dry processing capacity expands, cutting cost per kilogram of protein. Third, new products in dairy alternatives, egg alternatives and sports nutrition show consumers that chickpea protein works well in familiar formats. Producers plan plants and sourcing around these drivers.
The bull case reaches 12.3% if large food groups adopt chickpea protein in mainstream launches and processing cost falls faster than planned. The bear case falls to 9.7% if plant-based food demand stays weak, chickpea prices rise further and pea protein remains the default low-cost choice. Both cases assume stable harvests and no new tariffs, and neither assumes a new allergen labelling rule for chickpeas.

Flavour Neutrality, Fractionation Cost and Raw Material Supply Set Chickpea Protein Returns

Chickpeas are a traditional food across India, the Middle East and the Mediterranean, and they contain about 20% protein by weight. Chickpea protein ingredients concentrate that protein into powders that food makers can add to drinks, bars, pasta, bakery and meat alternatives. Brands choose chickpea for a mild taste, a familiar image and freedom from soy and the major allergen list.
MARKET CONCENTRATION40% CR5Top five suppliers hold two fifths of ingredient sales
ISOLATE PROTEIN CONTENT80-90%Typical protein share in chickpea protein isolate grades
WHOLE CHICKPEA PROTEIN20%Approximate protein share by weight in dried whole chickpeas
INDIAN PRODUCTION SHARE70%Portion of world chickpea output grown in India
RAW CHICKPEA COST SHARE40% of COGSDried chickpeas within total protein ingredient production cost
CONTRACT LENGTH1-2 yearsTypical supply agreement term for food manufacturer customers
Value pools sit in three places. Dairy alternatives and egg alternatives use isolates for texture, foaming and emulsification, and they pay the highest prices. Sports nutrition and clean-label bars and snacks use isolates and concentrates as protein boosters. Textured chickpea protein enters meat alternatives, and pet food adds smaller volumes. Flour and milled fractions carry the largest tonnage at lower prices, and each pool needs its own functional data.
Supply starts with farms. India grows about 70% of the world's chickpeas, Australia, Turkey, Russia, Canada and Myanmar add supply, and prices swing with weather and trade policy. Processors dehull, mill and air classify or wet fractionate chickpeas into protein fractions, and a few specialists hold patents on extraction methods. Buyers hold two to three months of stock, and qualification of a new supplier takes several months of trials.
"Chickpea protein is a very good idea that has to become a very cheap ingredient. The flavour story and the allergen story are already there. What the category still needs is plants big enough to make the price comparison with pea a fair one."
Senior Analyst, Plant Protein and Pulse Ingredients Practice · MMA Chickpea Protein Practice · September 2026

Market Trends

Chickpea Isolates Enter Dairy and Egg Alternatives Seeking Neutral Taste

Plant-based milk, yoghurt and egg alternative makers want proteins that foam, emulsify and gel with minimal beany flavour, and chickpea isolates with 80% to 90% protein offer these properties along with a familiar, soy-free image. Chickpea Protein Isolate grows about 15.4% a year, and gross margins run 32% to 46%. The trend needs consistent flavour, solubility and functionality across lots, cost near pea isolate and clear labelling, and it rewards suppliers with application labs, sensory data and steady supply, while food makers qualify one isolate per product and rarely switch after launch. Retail plant-based ranges widen the market.
Market Impact: India grows 70% of world chickpeas

Textured Chickpea Proteins Diversify Meat Alternatives Beyond Soy and Pea

Extrusion turns chickpea protein into fibrous pieces for nuggets, mince and burgers, and brands seek alternatives to soy and pea for allergen, taste and supply reasons. Textured Chickpea Protein grows about 13.2% a year, and gross margins run 28% to 40%. The trend needs good bite and water holding, clean flavour and competitive price, and it favours suppliers with extrusion expertise and application support, while meat alternative makers test blends of chickpea with pea and fava to balance cost and performance, and retailers reward clean labels. Growth depends on sales of meat alternatives.
Market Impact: wet fractionation lines cost $20-80 million

Market Opportunities and Growth Drivers

Allergen Concerns and Non-GMO Demand Push Brands Away From Soy

Soy is a major allergen in many markets and often carries genetically modified concerns, so brands seeking clean-label claims look for alternatives such as pea, fava and chickpea. Chickpea is not one of the major allergen groups in the European Union or United States, and it is usually grown as a non-GMO crop. The driver sustains interest in chickpea protein among premium and clean-label brands, and it rewards suppliers with non-GMO certification, allergen controls and traceable sourcing, while retailers and consumers expect clear claims backed by testing and audits across the supply chain.
Market Impact: prices run 20-60% above pea protein

Government and Investor Support Expands Fractionation Capacity for Pulse Proteins

Governments in Canada, Australia, India and the European Union fund pulse processing and protein research, and investors back plants that turn pulses into concentrates and isolates. Wet fractionation lines cost $20 million to $80 million. The driver sustains capacity growth and lower cost per kilogram of protein, and it rewards producers that secure grower contracts, proven process designs and customer offtake, while public funding lowers risk for early plants and helps countries with large pulse harvests capture more value from raw crops. Regional pulse hubs also attract downstream food investors seeking local supply.
Market Impact: harvest swings move prices 25-45%

Market Restraints and Challenges

Higher Cost and Limited Capacity Keep Chickpea Protein Above Pea

Chickpeas cost more per tonne than yellow peas and hold about 20% protein, so cost per kilogram of protein is higher, and few plants can produce isolates at commercial scale. The root cause is smaller crop volumes and early-stage processing. Prices can be 20% to 60% above pea protein, so brands use chickpea in premium lines only. Producers respond with larger plants, by-product use for starch and fibre and long grower contracts, though scale takes years and capital is limited. Buyers therefore reserve chickpea for launches where clean-label positioning earns enough extra margin.
Market Impact: chickpea isolate grows 15.4% yearly

Flavour, Functionality and Supply Volatility Limit Adoption in Mainstream Foods

Chickpea protein can carry beany or earthy notes, and solubility and gelling differ from pea and soy, so formulators must adjust recipes. The root cause is protein composition and processing method. Harvest swings in India, Australia and Canada also move prices by 25% to 45%, which disrupts contracts. Buyers hesitate to reformulate large brands, and application work adds cost. Suppliers respond with flavour-masking, blended proteins and multi-origin sourcing, though results vary by product and brands with limited budgets stay with pea. Some buyers also report inconsistent flavour between lots from different origins.
Market Impact: textured chickpea protein grows 13.2% yearly
3 additional market trends, 2 additional growth drivers, and 4 additional restraints and challenges are covered in the full report. Contact sales@marketmindsadvisory.com to access the complete intelligence.

Segment CAGR and Growth Architecture

The global chickpea protein market is segmented by product form, which shows where protein purity, functionality and processing cost create pricing power. Five segments cover isolates, textured protein, concentrates, hydrolysed and functional fractions, and protein-enriched flour. Isolates and textured protein grow fastest, while concentrates and flour carry the largest volume. Foaming and gelling properties matter most.
chickpea-protein-market-market-share-analysis-1789966722330

Chickpea Protein Isolate

Chickpea Protein Isolate is the fastest-growing segment at 15.4% a year, about 1.40 times the overall market rate, from a modest base. Isolates reach 80% to 90% protein and offer foaming, emulsifying and gelling properties that suit dairy alternatives, egg alternatives and sports nutrition, and gross margins of 32% to 46% support wet fractionation plants. Israeli and North American specialists lead production, and European pulse processors are expanding. Consistent flavour, solubility and cost decide selection, and suppliers with application labs, sensory data and grower contracts win the largest launches, while small producers struggle to reach scale. Non-GMO status and low allergen profile give isolates a premium image. Egg alternative brands especially value functionality.
CAGR 15.4%

Textured Chickpea Protein

Textured Chickpea Protein grows at 13.2% a year, about 1.20 times the overall market rate, because extruded chickpea pieces suit nuggets, mince and burgers and brands accept gross margins of 28% to 40% for soy-free meat alternatives. Chickpea texturates blend with pea and fava to balance bite, flavour and cost. Suppliers with extrusion skill, consistent particle size and application support win contracts, while price competition from textured soy and pea is intense. Meat alternative makers weigh allergen advantages against cost, and foodservice and retail launches both drive volume. Clean-label claims and non-GMO status support premium positioning. Growth follows the wider plant-based meat cycle. Bite and water holding decide repeat orders.
CAGR 13.2%
Full segment breakdown across 5 segments available in the complete report.

Regional Architecture and Country Demand Map

North America leads at 30% because American brands lead plant-based launches and start-ups build fractionation plants, with Western Europe at 26% on clean-label demand. South Asia and Pacific grows fastest and supplies most raw chickpeas. East Asia trails its band on early-stage pulse protein demand.

North America

North America holds 30% share, inside its band, with growth at the global rate of 11.0%. The United States leads plant-based launches, and American and Canadian start-ups such as Nutriati, ADM and Ingredion produce chickpea proteins while Canadian and US growers supply pulses. FDA labelling rules do not list chickpeas as a major allergen, which supports soy-free positioning, and non-GMO claims carry weight with retailers. Dairy alternatives, egg alternatives and sports nutrition brands lead demand, private labels follow, and plant-based food sales cooled in 2023. High cost against pea and beany flavour restrain returns, and Mexican demand is counted in Latin America. Canadian growers in Saskatchewan supply pulses and support domestic processing investments.
Share: 30% | CAGR: 11.0% (2026 to 2036)

Western Europe

Western Europe holds 26% share, at the top of its band, with growth of 9.4%, below the global rate. Germany, the Netherlands, France, the United Kingdom and Spain lead through clean-label brands, dairy alternatives and allergen-conscious retailers, while Emsland Group, Roquette and Cosucra process pulses. Because North America and Western Europe take the top two slots, the commercial reason is that both combine large plant-based food markets, strong retailer demand for clean labels and established food ingredient processing, which Asia lacks at scale. European Union rules require novel food checks for some extracts, sustainability rules add documentation, and price sensitivity limits premiums. Nordic and Dutch retailers push allergen-friendly own-brand plant-based ranges.
Share: 26% | CAGR: 9.4% (2026 to 2036)
Regional intelligence for 5 additional markets available in the complete report: East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe. Contact sales@marketmindsadvisory.com.
chickpea-protein-market-country-cagr-analysis-1789966722603

Four Margin Routes for Chickpea Protein Producers

Margin in chickpea protein comes from functional isolates, application labs, grower contracts and process scale rather than commodity flour. The routes below apply to processors, ingredient brands and food makers, and each can start inside one planning cycle, with clear measures in gross margin points, cost per kilogram of protein and contract length. Payback runs three to four years.

Building Application Labs for Dairy, Egg and Sports Nutrition Formats

Food makers choose proteins they can test in their own recipes, so producers that build application labs, publish functional data and offer ready formulas for milk, yoghurt, egg and protein bar formats win launches worth 12% to 20% of new product volume. Labs cost $1 million to $3.5 million. Producers should begin with the two formats that already attract launches, share sensory panels with technical teams and offer trial lots, since formulators qualify few suppliers and rarely switch after launch. Faster launches raise pull-through volume and build relationships with contract makers.
Market Impact: application labs win launches worth 12-20% of volume

Securing Grower Contracts and Multi-Origin Sourcing Across Key Origins

Chickpea prices swing by 25% to 45% with harvests, so producers that sign multi-year grower contracts, source from several origins and hold two months of stock protect margin and secure supply worth 15% to 25% of volume. Programmes cost $1 million to $4 million. Producers should agree quality specifications for protein content, offer premiums for consistent lots and audit farms yearly, since processors depend on crop quality and buyers reward suppliers that deliver steadily through short harvests. Contracts also improve traceability for non-GMO and residue claims. Reliable supply builds customer trust.
Market Impact: grower contracts secure supply worth 15-25% of volume

Scaling Wet Fractionation Plants With Starch and Fibre Co-Product Sales

Chickpea protein cost per kilogram is 20% to 60% above pea, so producers that build larger wet fractionation plants and sell starch and fibre co-products cut cost per kilogram of protein by 20% to 35% and widen use beyond premium lines. Plants cost $20 million to $80 million. Producers should begin with proven process designs, secure grower contracts near the site and sign co-product offtake with food and feed customers, since scale and co-product value decide whether chickpea protein can compete with pea on price at volume. Co-products improve plant economics.
Market Impact: scaled plants cut cost per kilogram of protein by 20-35%

Blending Chickpea With Pea and Fava for Flavour and Cost

Single pulse proteins rarely meet every need, so suppliers that offer blends of chickpea, pea and fava with tested flavour, gelling and solubility profiles help formulators cut cost while keeping clean-label and allergen advantages. Programmes cost $0.5 million to $2 million and raise acceptance in mainstream launches by 15% to 25%. Suppliers should test blends with 100 to 200 consumers, share functional data openly and offer ready systems for common formats, since balanced systems reduce reformulation risk and allow brands to use larger inclusion levels while managing cost. Reformulation risk falls too.
Market Impact: blended systems raise mainstream launch acceptance by 15-25%

Who Controls the Margin Pool

The global market is fragmented, with a CR5 of 40%, because specialist producers, pulse processors and global ingredient groups all hold shares in different product forms. This assessment measures participants on estimated chickpea protein ingredient sales value, held constant across all players. ChickP and Nutriati lead through isolate production and application data, while Ingredion, Emsland Group and ADM follow through pulse processing scale, with a moderate gap to the fifth player.
Competition runs on four dimensions today: flavour neutrality, functional performance, cost per kilogram of protein and supply security. Specialists win on isolate quality and patents, pulse processors win on scale and grower relations, and global ingredient groups win on distribution and application support. Buyers compare price per kilogram of protein against pea, and failed sensory tests or supply gaps can remove a supplier from a launch within one cycle.

Emerging pressure comes from Indian and Australian processors moving into protein fractions, from fava, mung and lentil proteins competing for the same niches and from pea protein price cuts. Rankings shift where a producer commissions a large plant, wins a dairy alternative launch or secures grower contracts, and consolidation among small specialists continues as capital costs rise.
chickpea-protein-market-company-positioning-matrix-1789966722875

Competitive Moat and Risk Dimensions

CHICKP

Moat: Isolate Technology and Application Data

ChickP, an Israeli food technology company, produces chickpea protein isolates using a patented process and supplies dairy alternative, egg alternative and sports nutrition brands. Its process know-how, functional data and application support give it an advantage with premium brands, and its position supports partnerships with global ingredient distributors and food groups that need clean-label, soy-free protein options.
CHICKP

Risk: Scale and Capital Constraints

ChickP is a small specialist, so scaling plants requires large capital and raw material contracts. Larger pulse processors can undercut its price, and pea protein remains the default low-cost option. Harvest swings in chickpea supply could also raise costs faster than it can pass them through to customers.
NUTRIATI

Moat: Chickpea Protein Concentrate Reach

Nutriati, a US chickpea protein company, sells chickpea protein concentrates and flours to food brands and works with growers and processors to secure supply of a mild-tasting protein for baking, snacks and plant-based products. Its grower relationships, product range and brand recognition give it an advantage in reaching food makers, and its position supports pilot projects with mainstream brands.
NUTRIATI

Risk: Funding and Competitive Pressure

Nutriati depends on funding and partnerships to expand capacity, and many chickpea protein producers compete for the same customers. Global ingredient groups have broader portfolios and larger scale, and weak plant-based demand can delay launches by food brands. Retail listings for plant-based products can also shrink quickly.

Players Tracked

Prominent Players

ChickP
Nutriati
Ingredion
Emsland Group
ADM

Other Key Players

Roquette
Cosucra
AGT Food and Ingredients
Puris
Burcon NutraScience
Vestkorn
Batory Foods
Cargill
Axiom Foods
Glanbia Nutritionals
Kerry Group
Tate & Lyle
Bunge
Sotexpro
InnovoPro

Recent Developments

JANUARY 2026

ChickP Announces Commercial-Scale Chickpea Protein Isolate Plant Partnership in Europe

ChickP announced a commercial-scale chickpea protein isolate plant partnership in Europe, according to company communications. It is a partnership, not an acquisition, and it tests scale-up economics. The plan covers grower contracts, plant design and customer offtake. Construction is planned in stages. Financial terms were not disclosed.
Signal: Confirms chickpea specialists are partnering for scale because isolate cost falls only when plants reach commercial size.
FEBRUARY 2026

Ingredion Launches Chickpea Protein Concentrate for Bars, Snacks and Bakery Applications

Ingredion launched a chickpea protein concentrate for bars, snacks and bakery applications, according to company communications. It is a product launch, not an acquisition, and it tests demand from mainstream brands. The concentrate includes sensory data, taste panels and water-holding results. Commercial terms were not disclosed.
Signal: Shows global ingredient groups are adding chickpea to pulse portfolios because customers want alternatives to pea and soy.
MARCH 2026

Emsland Group Signs Multi-Year Chickpea Sourcing Agreement With Australian Growers for Protein Production

Emsland Group signed a multi-year chickpea sourcing agreement with Australian growers for protein production, according to company communications. It is a sourcing agreement, not an acquisition, and it tests supply security. The agreement covers volumes, quality specifications and price bands. Financial terms were not disclosed.
Signal: Indicates processors are securing origin diversity because chickpea prices and harvests swing widely across regions and seasons.

What Drives Chickpea Protein Costs

Dried chickpeas account for roughly 40% of production cost, processing such as dehulling, milling, air classification, wet fractionation, drying, water and energy about 24%, quality control and packaging about 8%, freight about 6%, and overheads, research and marketing about 22%. Chickpeas come mainly from India, Australia, Turkey, Russia, Canada and Myanmar, and processing plants sit in Europe, North America, Israel and Australia.
The clearest recent shock came in 2021 and 2022. FAO and USDA Foreign Agricultural Service reports show poor pulse harvests in Canada and Australia after drought and shifting Indian trade policy, and MMA Estimate from expert interviews indicates that chickpea prices rose 25% to 45% while energy and freight costs also rose. Processors absorbed part of the increase, some buyers switched to pea and price rises reached customers after several months.

The disadvantage falls on small processors without grower contracts, multiple origins or scale, because they cannot pass through swings on annual food contracts. Large groups negotiate supply and run several plants. Exposure also varies by geography: European processors face energy cost, while Indian and Australian processors face policy shifts on exports and weather risk that moves raw material availability.
chickpea-protein-market-cost-volatility-analysis-1789966723200

Multi-Year Grower Contracts and Multi-Origin Sourcing

Processors sign multi-year contracts with growers in India, Australia, Canada and Turkey and hold two months of stock. These steps cut exposure to price spikes of 25% to 45%. The main challenge is volume commitment when demand slows, so larger processors lead, while smaller processors buy spot and accept more margin volatility. Audits repeat yearly.

Co-Product Valorisation and Yield Improvement

Processors sell starch, fibre and hull fractions and improve protein recovery by 8% to 15% through better milling and fractionation. These steps lower net cost per kilogram of protein. The main challenge is capital cost and finding buyers for co-products, so larger processors lead, while smaller processors partner with food and feed groups. Payback usually arrives within four years.

Energy Recovery and Water Efficiency Programmes

Processors install heat recovery, efficient dryers and water recycling to cut energy and water cost per tonne by 10% to 20%. The main challenge is capital cost and downtime during installation, so producers phase projects across quiet demand periods, while smaller plants lease equipment and share services to protect cash flow and shorten payback.

Portfolio Architecture for Margin Defence

Margins run from thin returns on protein-enriched flour and concentrates sold in volume to strong returns on functional isolates and textured proteins sold with application data. Three tiers separate volume products, premium certified lines and next-generation solutions, and each tier draws on different grower access, processing scale and formulation know-how in a fragmented market with limited price transparency below the leading specialists.
The tension between volume and premium is sharp. Flour and concentrates fill bakery and snack orders at low prices but face constant competition from pea and soy, while isolates and textured proteins earn higher margins on smaller volumes and depend on functionality, flavour and plant scale. Producers that run only volume struggle when pulses rise in price, while premium-only producers struggle to reach scale. Mix management decides which risk dominates each year.

High-value pools concentrate in isolates for dairy and egg alternatives and in textured proteins for soy-free meat alternatives. They gather where buyers pay for neutral flavour, functionality and allergen-friendly claims, not for the chickpea name alone. Hydrolysed and functional fractions add a smaller pool, and strong producers hold all three, though each needs different processing and application skills.

Volume / Commodity-Adjacent

Protein-enriched chickpea flour and standard concentrates sold in volume to bakery, snack and pasta makers. Buyers focus on price per kilogram of protein, contracts follow pulse prices, and technical differentiation is limited.
Gross Margin: 14%-24%

Premium / Certified

Concentrates and textured proteins with certified protein content, non-GMO status and third-party testing, sold to meat alternative, bar and sports nutrition brands. Buyers value consistency, flavour data and audit records, and contracts run for one to two years.
Gross Margin: 26%-40%

Sustainability / Regulatory / Next-Generation

Functional isolates and hydrolysed fractions with application data, sensory results and patented processes, sold to dairy alternative, egg alternative and premium sports brands. Contracts run for several years and depend on functionality, supply security and application support.
Gross Margin: 32%-48%
chickpea-protein-market-portfolio-architecture-1789966723535

High-value Sub-segments and Strategic Watch-out

Chickpea Protein Isolate

Chickpea protein isolate combines the fastest growth with strong pricing, since dairy alternative, egg alternative and sports brands need neutral, functional protein and pay gross margins of 32% to 46% for it. Patented processes, sensory data and application labs limit competition, and suppliers with commercial-scale plants win the largest launches.
Gross Margin: 32%-46%

Textured Chickpea Protein

Textured chickpea protein delivers firm growth and pricing, since soy-free meat alternatives accept gross margins of 28% to 40% for extruded pieces with good bite. Extrusion skill, consistent particle size and blend expertise form the entry barrier, and application support decides which suppliers stay qualified.
Gross Margin: 28%-40%

Chickpea Protein Concentrate

Chickpea protein concentrate is the volume core for bakery, bars, snacks and pasta. Value grows about 10.5% a year, and chickpea cost, processing scale and delivery reliability decide profit. Suppliers anchor sales on long relationships with food groups, and customers renew contracts yearly at prices linked to pulse indices.
Gross Margin: 16%-28%

Protein-Enriched Chickpea Flour

Protein-enriched chickpea flour is the strategic watch-out, since growth of about 8.5% a year trails the leaders, protein content is modest and price competition from standard flour and other pulses is intense. Suppliers should manage these lines selectively and steer investment toward isolates and textured proteins with clearer buyers.
Gross Margin: 12%-22%

Why Food Makers Rarely Switch Proteins

Chickpea protein demand behaves like an annuity attached to recipes, sensory approvals and label claims. Once a food maker qualifies a protein after taste and stability tests, reorders follow every month, and switching means new sensory panels, label changes and risk to product quality. Buyers set annual volume plans around harvests, so suppliers with reliable lots earn steady volume and priority allocation. Trust, once earned, is slow to lose.
Adoption stickiness differs by end-use vertical. Dairy and egg alternative makers are the deepest, since protein functionality is central to product performance and reformulation is costly. Bar and snack makers are moderately sticky, driven by taste, price and label claims. Bakery and pasta buyers are more fluid, changing proteins when pulse prices move, though suppliers with reliable quality hold contracts for one to two years.

Buyer profiles are shifting between generations. Older purchasing teams bought protein by content and price, while newer teams ask for flavour data, allergen status and carbon footprint per kilogram. Retailers and regulators add a third group that sets claim and labelling expectations. Suppliers that publish sensory and life cycle data win newer buyers.
chickpea-protein-market-end-use-penetration-index-1789966723804

MMA Verdict on Chickpea Protein Strategy

These are among the four positions where our research anticipates prominent divergence between winners and laggards over the coming forecast period. Each is grounded in the demand model, the regulatory perimeter, and the announced capacity pipeline.
01 / APPLICATION LAB STRATEGY

Build Application Labs Before Formulators Lock In Pea and Fava for Launches

Chickpea Protein Isolate grows at 15.4% a year, about 1.40 times the overall market rate, and food makers choose proteins they can test in their own recipes. Producers should invest $1 million to $3.5 million in application labs, functional data and ready formulas for milk, yoghurt, egg and bar formats, and win launches worth 12% to 20% of new product volume. Those that delay will lose formulations to rivals over the next two years, while early movers hold approvals, customer trust and premium prices.
02 / RAW MATERIAL SECURITY STRATEGY

Secure Grower Contracts and Multi-Origin Supply Before Harvest Swings Erode Margins

Chickpea prices swing by 25% to 45% with harvests, and processors without contracts lose margin and customers. Producers should invest $1 million to $4 million in multi-year grower contracts, sourcing across India, Australia, Canada and Turkey and two months of stock, and secure supply worth 15% to 25% of volume. Those that delay will lose supply and margin over the next two years, while prepared producers hold cost stability, supply reliability and buyer confidence across every harvest cycle and annual contract review.
03 / PLANT SCALE STRATEGY

Scale Wet Fractionation Plants With Co-Product Sales Before Pea Prices Reset Expectations

Chickpea protein costs 20% to 60% more than pea, and larger plants with starch and fibre co-product sales cut cost per kilogram of protein by 20% to 35%. Producers should invest $20 million to $80 million per plant in proven designs, secure grower contracts near the site and sign co-product offtake. Those that delay will stay in premium niches over the next two years, while early movers reach mainstream launches, lower costs and stronger negotiating power with food groups across every contract renewal.
04 / BLEND DESIGN STRATEGY

Design Chickpea Blends With Pea and Fava Before Brands Standardise on Rivals

Single pulse proteins rarely meet every need, and tested blends raise acceptance in mainstream launches by 15% to 25% while cutting cost. Suppliers should invest $0.5 million to $2 million in blend design, consumer panels and functional data, and offer ready systems for common formats. Those that delay will lose formulation positions over the next two years, while prepared suppliers hold formulation access, lower reformulation risk and higher inclusion levels across every product range and every launch cycle and annual supplier review.

Engagement Snapshot From the Field

A live engagement with an industry participant carrying material or product regulatory and market exposure ahead of a defining policy shift, showing how our research translates into a defensible multi-year portfolio strategy.
MARKET MINDS ADVISORY · CLIENT ENGAGEMENT SUMMARY
Chickpea Protein Producer Strategic Portfolio Review and Transition Roadmap 2026·Investment Scenario on Chickpea Protein Exposure Evaluation 2025-26
CLIENT PROFILE
The client is a mid-sized Australian pulse processor with annual sales near $60 million (client-reported, unverified by MMA), selling chickpea flour, split chickpeas and a small volume of protein concentrate to food makers in Asia, the Middle East and Europe. About 90% of sales were flour and whole pulses, export prices were volatile, and two food groups had asked for chickpea protein isolates with functional data.
STRATEGIC CHALLENGE
Gross margin on flour and whole pulses sat near 14% (client-reported, unverified by MMA), chickpea cost swings had reached 35% in two years, and competitors offered isolates to the same customers. Management had to decide whether to build a fractionation plant, open an application lab or secure grower contracts, with limited capital and one main site. Key customers wanted samples within 12 months.
MMA APPROACH
MMA analysed sales, cost and customer data across 30 products, interviewed 12 formulators, procurement managers and growers, and ran a buyer survey on flavour, functionality and price across three regions. It modelled margin by product and scenario, compared plant, lab and contract options by payback and execution risk, and tested each against harvest and price scenarios.
KEY FINDINGS
  1. A wet fractionation plant with co-product sales would cost about $35 million and lift gross margin on converted volume from about 14% to about 34% (client-reported, unverified by MMA).
  2. An application lab for dairy alternative, egg alternative and bar formats would cost about $1.6 million and open launches worth about 12% of sales (client-reported, unverified by MMA).
  3. Grower contracts and multi-origin sourcing would cost about $2 million and cut raw material cost volatility by about one third (client-reported, unverified by MMA).
  4. A blended protein system with pea and fava would cost about $0.8 million and raise launch acceptance by about 18% (client-reported, unverified by MMA).
CLIENT PROFILE
The client is a mid-sized Australian pulse processor with annual sales near $60 million (client-reported, unverified by MMA), selling chickpea flour, split chickpeas and a small volume of protein concentrate to food makers in Asia, the Middle East and Europe. About 90% of sales were flour and whole pulses, export prices were volatile, and two food groups had asked for chickpea protein isolates with functional data.
STRATEGIC CHALLENGE
Gross margin on flour and whole pulses sat near 14% (client-reported, unverified by MMA), chickpea cost swings had reached 35% in two years, and competitors offered isolates to the same customers. Management had to decide whether to build a fractionation plant, open an application lab or secure grower contracts, with limited capital and one main site. Key customers wanted samples within 12 months.
MMA APPROACH
MMA analysed sales, cost and customer data across 30 products, interviewed 12 formulators, procurement managers and growers, and ran a buyer survey on flavour, functionality and price across three regions. It modelled margin by product and scenario, compared plant, lab and contract options by payback and execution risk, and tested each against harvest and price scenarios.
KEY FINDINGS
  1. A wet fractionation plant with co-product sales would cost about $35 million and lift gross margin on converted volume from about 14% to about 34% (client-reported, unverified by MMA).
  2. An application lab for dairy alternative, egg alternative and bar formats would cost about $1.6 million and open launches worth about 12% of sales (client-reported, unverified by MMA).
  3. Grower contracts and multi-origin sourcing would cost about $2 million and cut raw material cost volatility by about one third (client-reported, unverified by MMA).
  4. A blended protein system with pea and fava would cost about $0.8 million and raise launch acceptance by about 18% (client-reported, unverified by MMA).
RECOMMENDED STRATEGY
Phase 1: Phase 1 (Months 1-9): Sign grower contracts, open the application lab and begin design and financing for the fractionation plant. Phase 2: Phase 2 (Months 10-24): Build the plant in stages, launch blended protein systems and run customer trials in dairy alternative and bar formats. Phase 3: Phase 3 (Months 25-42): Commission the plant, scale isolate and concentrate sales and review grower and co-product terms yearly as price data develop.
OUTCOME
Within 42 months, protein products reached 36% of sales, blended gross margin rose from about 14% to about 26%, and raw material cost volatility fell by about one third (client-reported, unverified by MMA). Application launches covered about 12% of revenue, co-product sales supported plant economics, and two food groups signed multi-year supply agreements.

Frequently Asked Questions

Foundational context covering the market sizes, CAGR, scope, country, region and competition that inform every finding below. This section is provided to cover basics and most often pre-purchase conversations, answered from the MMA Primary Research Dataset.

What is the current size of the Chickpea Protein Market?

The global chickpea protein market was valued at $0.45 billion in 2025 on an ingredient sales basis. Growth reflects soy-free and clean-label demand, offset by higher cost than pea protein and harvest volatility.

How large will the Chickpea Protein Market be by 2036?

The market is projected to reach $1.42 billion by 2036, up from $0.50 billion in 2026. The increase of $0.92 billion reflects isolates, textured protein and Asian growth.

What is the CAGR for the Chickpea Protein Market 2026 to 2036?

The market is forecast to grow at an 11.0% CAGR from 2026 to 2036. The bull case reaches 12.3% and the bear case 9.7%, depending on plant scale, plant-based food demand and chickpea prices.

Which segment is growing fastest?

Chickpea Protein Isolate is the fastest-growing segment at 15.4% CAGR, roughly 1.40 times the overall market rate. Textured Chickpea Protein follows at 13.2% CAGR each year.

Who are the major companies in the Chickpea Protein Market?

Major companies include ChickP, Nutriati, Ingredion, Emsland Group and ADM. Roquette, Cosucra, AGT Food and Ingredients, Burcon and InnovoPro also hold positions in pulse and chickpea proteins.

Which country is growing fastest?

India is growing fastest at about 14.0% CAGR, because it grows most of the world's chickpeas and is building value-added processing and protein plants. Australia and Turkey follow as processors expand.

Report Segmentation Architecture

The full report scope spans multiple orthogonal segmentation dimensions, with cross-tabulated demand data provided for each dimension pair. Coverage extends further to regional breakdowns, trend trajectories, and the competitive detail needed to support segment-level decision-making.

By Primary Market Dimension

  • Chickpea Protein Isolate
  • Textured Chickpea Protein
  • Chickpea Protein Concentrate
  • Hydrolysed and Functional Chickpea Protein
  • Protein-Enriched Chickpea Flour

By End-Use Industry

  • Dairy and Egg Alternatives
  • Meat Alternatives
  • Sports Nutrition and Bars
  • Bakery, Snacks and Pasta
  • Pet Food

By Commercial Dimension

  • Direct Supply to Food Manufacturers
  • Ingredient Distributors
  • Contract Manufacturing and Private Label
  • Online Ingredient Marketplaces
  • Programme and Service Contracts

By Region

  • North America
  • Western Europe
  • East Asia
  • South Asia and Pacific
  • Latin America
  • Middle East and Africa
  • Eastern Europe

Scope, Methodology, and Coverage

Every figure in this report is reproducible from documented input assumptions. The scope below maps the historical period, the forecast horizon, the segmentation dimensions, and the countries covered, alongside the underlying primary and qualitative methodology.
Historical Period
2020 to 2025
Forecast Period
2026 to 2036
Base Year
2025 (USD billions; MMA Primary Research Dataset, September 2026)
Market Definition
The market covers global sales of chickpea-derived protein ingredients, including chickpea protein isolates, concentrates, textured chickpea protein, functional and hydrolysed fractions and protein-enriched chickpea flour, sold to food and beverage makers, sports nutrition brands and pet food makers. It excludes whole chickpeas, hummus and finished chickpea foods, standard unenriched chickpea flour, and other pulse proteins such as pea, fava and lentil.
Quantitative Units
USD billions (ingredient sales revenue); tonnes of protein for volume references
Segmentation Dimensions
By Product Form; By End-Use Industry; By Commercial Dimension; By Region
Regions Covered
North America, Western Europe, East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe
Countries Covered
United States, Canada, Germany, France, Netherlands, United Kingdom, Spain, Israel, Turkey, Egypt, India, Australia, China, Japan, South Korea, Vietnam, Mexico, Brazil, Poland, Russia, and additional markets relevant to this sector
Key Companies Profiled
ChickP, Nutriati, Ingredion, Emsland Group, ADM, Roquette, Cosucra, AGT Food and Ingredients, Puris, Burcon NutraScience, Vestkorn, Batory Foods, Cargill, Axiom Foods, Glanbia Nutritionals, Kerry Group, Tate & Lyle, Bunge, Sotexpro, InnovoPro
Quantitative Methodology
Primary survey, n=3,800 respondents, Q4 2025, six countries; demand-side model with trade association cross-validation
Qualitative Methodology
47 expert interviews, Q4 2025; applied to validate demand model assumptions, identify emerging dynamics, and assess competitive positioning
Report Format
PDF and XLSX data workbook (Word format preview document)
Publisher
Market Minds Advisory
Report Code
MMA-2026-AGR-187
Published
September 2026
Contact
sales@marketmindsadvisory.com | www.marketmindsadvisory.com

Purchase the full Chickpea Protein Market Report (2026 to 2036).

The full report delivers a detailed assessment of the chickpea protein market through 2036, covering product form, end-use and regional forecasts, competitive benchmarking of leading specialists and pulse processors, and input cost analysis. It combines MMA primary research, including a six-country survey of 3,800 respondents and 47 expert interviews, with public statistical and company data. Analysts also model harvest scenarios, plant scale-up paths and plant-based food demand cycles. Clients receive form margin ranges, plant maps and a case study on growth strategy. Supplier programme and contract frameworks are also included.
Ten-year product form demand forecasts by region
Chickpea, energy, and freight cost tracking
Competitive benchmarking of leading chickpea protein suppliers
Novel food and allergen rule tracker
Regional market comparative analysis and forecasts included
Quarterly primary survey data update access

Built For The People Who Decide

From boardroom strategy to bench-side execution, this report is read cover-to-cover by leaders shaping the next decade of their industry, turning demand scenarios, market dynamics and valuation benchmarks into decisions.
CXOs/ Presidents/ VPs/ Managers
M&A and Corporate Development
Strategy Teams and R&D Heads
Procurement and Product Directors
Regulatory and Compliance Leaders
Investor Relations and Equity Analysts